1. Role of McbR in the regulation of antibiotic susceptibility in avian pathogenic Escherichia coli
- Author
-
Fei Shang, Ting Xue, Wenchang Li, Lumin Yu, Zhichao Liu, Wenhui Wang, and Jiangliu Yu
- Subjects
avian pathogenic Escherichia coli ,Nalidixic acid ,Tetracycline ,Genetics and Molecular Biology ,Microbial Sensitivity Tests ,Microbiology ,03 medical and health sciences ,Pathogenic Escherichia coli ,Drug Resistance, Bacterial ,Escherichia coli ,medicine ,Animals ,McbR ,Escherichia coli Infections ,Poultry Diseases ,Norfloxacin ,Novobiocin ,lcsh:SF1-1100 ,030304 developmental biology ,0303 health sciences ,biology ,Escherichia coli Proteins ,0402 animal and dairy science ,Kanamycin ,04 agricultural and veterinary sciences ,General Medicine ,biochemical phenomena, metabolism, and nutrition ,biology.organism_classification ,040201 dairy & animal science ,Anti-Bacterial Agents ,Lincomycin ,efflux pump ,Animal Science and Zoology ,lcsh:Animal culture ,Efflux ,antibiotic susceptibility ,Transcription Factors ,medicine.drug - Abstract
Avian pathogenic Escherichia coli (APEC) causes a variety of bacterial infectious diseases known as avian colibacillosis leading to significant economic losses in the poultry industry worldwide and restricting the development of the poultry industry. The development of efflux pumps is one important bacterial antibiotic resistance mechanism. Efflux pumps are capable of extruding a wide range of antibiotics out of the cytoplasm of some bacterial species, including β-lactams, polymyxins, tetracyclines, fluoroquinolones, aminoglycosides, novobiocin, nalidixic acid, and fosfomycin. In the present study, we constructed the mcbR mutant and the mcbR-overexpressing strain of E. coli strain APECX40 and performed antimicrobial susceptibility testing, antibacterial activity assays, real-time reverse transcription PCR, and electrophoretic mobility shift assays (EMSA) to investigate the molecular regulatory mechanism of McbR on the genes encoding efflux pumps. Our results showed that McbR positively regulates cell susceptibility to 12 antibiotics, including clindamycin, lincomycin, cefotaxime, cefalexin, doxycycline, tetracycline, gentamicin, kanamycin, norfloxacin, ofloxacin, erythromycin, and rifampicin by activating the transcription of acrAB, acrD, emrD, and mdtD (P
- Published
- 2020
- Full Text
- View/download PDF